double-skinned crabsVietnamese crab exporter
Advertisement
Medicine
OpinionLetters

LettersWhy lifestyle medicine belongs in Asia’s nasopharyngeal cancer conversation

Readers discuss a form of cancer endemic to East and Southeast Asia, the impact of the disruption to oil supply on Asian cities, and EU support for Ukraine

3-MIN READ3-MIN
Listen
People smoke traditional and e-cigarettes in Causeway Bay in January 2025. Smoking is one of the risk factors for nasopharyngeal cancer. Photo: Nora Tam
Letters
Feel strongly about these letters, or any other aspects of the news? Share your views by emailing us your Letter to the Editor at [email protected] or filling in this Google form. Submissions should not exceed 400 words.

The end of April marked the end of Head and Neck Cancer Awareness Month, offering a reminder that one disease deserves greater attention in Asia: nasopharyngeal carcinoma (NPC), a type of head and neck cancer. NPC has a strikingly uneven geography. It remains endemic in East and Southeast Asia, where the majority of cases occur.

The regional burden is easy to see. In Hong Kong, the Centre for Health Protection recorded 700 new NPC cases in 2023, 549 in men and 151 in women. According to the International Agency for Research on Cancer’s recent estimates, Indonesia recorded 18,835 new nasopharyngeal cancer cases in 2022, also with a particularly heavy male burden: NPC was the fourth most common cancer in men, accounting for 14,497 new cases or 7.7 per cent of all new male cancers. These numbers reflect a cancer burden that merits wider awareness and discussion.

Select Voice
Select Speed
1x
AI-generated voice